Substrate specificity of strictosidine synthase

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 9, 2006, Pages 2475-2478

  McCoy, Elizabeth ^a   Galan, M Carmen ^a   O'Connor, Sarah E ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Alkaloids; Biosynthesis; Enzyme catalysis; Glycosidase; Pictet Spengler

Indexed keywords

4 FLUOROTRYPTAMINE; 5 FLUOROTRYPTAMINE; 6 FLUOROTRYPTAMINE; 7 FLUOROTRYPTAMINE; ALDEHYDE DERIVATIVE; AMINE; BENZOFURAN DERIVATIVE; INDOLE ALKALOID; SECOLOGANIN; STRICTOSIDINE; STRICTOSIDINE SYNTHASE; SYNTHETASE; TERPENE DERIVATIVE; TRYPTAMINE; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME SPECIFICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PICTET SPENGLER REACTION; QUANTITATIVE ANALYSIS;

ALKALOIDS; CARBON-NITROGEN LYASES; CATALYSIS; ENZYME ACTIVATION; GLUCOSIDASES; INDOLE ALKALOIDS; INDOLES; KINETICS; MOLECULAR STRUCTURE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; TERPENES; VINCA ALKALOIDS;

EID: 33644990230     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.01.098     Document Type: Article

References (30)

1. R. van der Heijden, D.I. Jacobs, W. Snoeijer, H. Didier, and R. Verpoorte Curr. Med. Chem. 11 2004 607
2. J.F. Treimer, and M.H. Zenk Eur. J. Biochem. 101 1979 225
3. H. Mizukami, H. Nordlov, S.-L. Lee, and A.I. Scott Biochemistry 18 1979 3760
4. J.F. Treimer, and M.H. Zenk FEBS Lett. 97 1979 159
5. T.M. Kutchan Phytochemistry 32 1993 493
6. I. Gerasimenko, Y. Sheludko, X. Ma, and J. Stockigt Eur. J. Biochem. 269 2002 2204
7. A. Geerlings, M.M.-L. Ibanez, J. Memelink, R. Van der Heijden, and R. Verpoorte J. Biol. Chem. 275 2000 3051
8. U. Pfitzner, and M.H. Zenk Methods Enzymol. 136 1987 342
9. T.M. Kutchan, N. Hampp, F. Lottspeich, K. Beyreuther, and M.H. Zenk FEBS Lett. 237 1988 40
10. E.J. Pennings, R.A. van den Bosch, R. van der Heijden, L.H. Stevens, J.A. Duine, and R. Verpoorte Anal. Biochem. 176 1989 412
11. T.D. McKnight, C.A. Roessner, R. Devagupta, A.I. Scott, and C. Nessler Nucleic Acids Res. 18 1990 4939
12. D. Bracher, and T.M. Kutchan Arch. Biochem. Biophys. 294 1992 717
13. C.A. Roessner, R. Devagupta, M. Hasan, H.J. Williams, and I.A. Scott Protein Expr. Purif. 3 1992 295
14. T.M. Kutchan, A. Bock, and H. Dittrich Phytochemistry 35 1994 353
15. A. de Waal, A.H. Meijer, and R. Verpoorte Biochem. J. 306 1995 571
16. Although a structure is not yet reported, the enzyme has been crystallized. J. Koepke, X. Ma, G. Fritzsch, H. Michel, and J. Stoeckigt Acta Crystallogr., Sect. D D61 2005 690
17. + expect. 557.2, obsd 557.2). Synthesis of authentic standards (diastereomeric mixtures) and evaluation of chemical reaction rates was performed by reacting amine and aldehyde substrates (20 mM concentration) under aqueous conditions (150 mM maleic acid, pH 2).
18. Compounds 11 and 13 were synthesized from the corresponding commercially available indole-3-carbaldehydes as previously reported. (Harada, H.; Hirokawa, Y.; Suzuki, K.; Hiyama, Y.; Oue, M.; Kawashima, H.; Yoshida, N.; Furutani, Y.; Kato, S. Bioorg. Med. Chem. Lett. 2003, 13, 1301.)
19. Substrates 10 and 7 were synthesized from the corresponding commercially available indoles as previously described. (Chen, Z.; Cohen, M. P.; Fisher, M. J.; Giethlen, B.; Gillig, J. R.; McCowan, J. R.; Miller, S. C.; Schaus, J. M. Preparation of N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor.: USA, 2002; p 216.)
20. Benzofuran (4) and benzothiophene (5) derivatives were generated from reduction of the commercially available nitrile compounds. (Shafiee, A.; Mohamadpour, M. J. Heterocycl. Chem. 1978, 15, 481.)
21. The pyrrole ethanamine compound (16) was synthesized as described. (Wasley, J. W. F.; Hamdan, A. Synth. Commun. 1985, 15, 71.) All other tryptamine analogs were commercially available.
22. N. Samanani, D.K. Liscombe, and P.J. Facchini Plant J. 40 2004 302
23. R.E. Mewshaw, D. Zhou, P. Zhou, X. Shi, G. Hornby, T. Spangler, R. Scerni, D. Smith, L.E. Schechter, and T.H. Andree J. Med. Chem. 47 2004 3823
24. Synthesis of these derivatives is described in Galan, M. C.; O'Connor, S. E. Tetrahedron Lett. 2006, 47, 1563.
25. 3OH, 7:3) to yield purified secologanin (1 g). NMR and mass spectral data matched previously reported values
26. L. Barleben, X. Ma, J. Koepke, G. Peng, H. Michel, and J. Stoeckigt Biochim. Biophys. Acta 1747 2005 89
27. J. Roquebert, and P. Demichel Eur. J. Pharmacol. 106 1984 203
28. S. Li, J. Long, Z. Ma, Z. Xu, J. Li, and Z. Zhang Curr. Med. Res. Opin. 20 2004 409
29. P.R.H. Moreno, R. Van der Heijden, and R. Verpoorte Plant Cell Tissue Org. Cult. 42 1995 1
30. + expect. 365.4, obsd 365.5).